Market Access with HAS: Your Guide to France’s Leading Health Authority

The Haute Autorité de Santé (HAS), or French National Authority for Health, is an independent public authority established in 2004 and is France’s national Health Technology Appraisal (HTA) body. HAS aims to improve the quality of patient care and ensure equity within the healthcare system. Its activities include evaluating drugs, medical devices, and procedures, publishing guidelines, and accrediting healthcare organizations. (has-sante.fr)

Core Functions of HAS

HAS’s primary responsibilities include:

•     Market access HAS evaluations / HTA appraisals: Assessing the medical benefit and economic value of drugs, medical devices, and professional practices to inform reimbursement decisions. (has-sante.fr)
  
•     Expert consultant HAS recommendations: Publishing guidelines for healthcare professionals to promote best practices and improve patient outcomes.
  
•     Specialist HAS accreditation: Certifying hospitals and clinics to ensure quality and safety in patient care.
  
  

Leadership and Key Contacts

As of January 2025, HAS is led by President Professor Lionel Collet, who oversees the organization’s strategic initiatives and operations. (has-sante.fr)

Transparency Commission (Commission de la transparence, CT): led by Pr Pierre Cochat

Commission for medical devices and health technologies (Commission nationale d’évaluation des dispositifs médicaux et des technologies de santé, CNEDiMTS): led by Dr Jean-Yves Grall

Economic Evaluation and Public Health Commision (Commission d’évaluation économique et de santé publique, CEESP): led by Pr Karine Chevreul

Technical Commission on vaccinations (Commission technique des vaccinations, CTV): led by Pr Anne-Claude Crémieux

Contact Details for HAS

Website: https://www.has-sante.fr/

Address:
Haute Autorité de Santé
5 avenue du Stade de France
93218 Saint-Denis La Plaine Cedex, France

Telephone: +33 (0)1 55 93 70 00

Challenges in Working with HAS

Engaging with HAS involves:

•     Understanding market access HAS processes: Familiarity with HAS’s assessment criteria and submission requirements is crucial for successful market access. This includes e.g. knowledge of the doctrine of the Transparency Commission and the methodological requirements
•     Timely and accurate submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate the evaluation process.
•     Stakeholder collaboration: Working effectively with various healthcare stakeholders in France to align with HAS’s guidelines and recommendations.

Successful collaboration with HAS can lead to efficient market entry and favorable reimbursement outcomes in France.

Opportunities / Solutions with Justin Stindt Consultants

Justin Stindt HAS expertise ensures:

•     Expert consultant HAS submissions: Creating high-quality submissions for the Transparency Commission, CNEDiMTS, and CEESP.
•     Early dialogue scientific advice meetings (rencontre précoce) and pre-submission meetings
•     Market access HAS strategies: Proven methods for optimizing reimbursement outcomes.
•     Specialist HAS processes and hearings: In-depth knowledge of French HTA evaluations and HTA engagements to accelerate approvals.
•     Leverage of our network of payers and KOLs such as: Former members of HAS and its relevant commissions, leading KOLs and payer advisors, current & former TC members and advisers, and former members and advisers of CEPS

Expert HAS Support

•     Expert HAS guidance: Our team provides direct support for market access and reimbursement challenges.
•     Expert HAS insights: We help you navigate HAS evaluations with a tailored approach.
•     Expert HAS documentation: Ensuring accurate submissions that meet HTA expectations.

Justin Stindt Consultants specializes in helping clients optimize submissions to the Transparency Commission,  CNEDiMTS  and CEESP and navigate HAS evaluations with confidence.